However, as shown in Figure S2a,b, the expression analysis of Tau-total and Tau-phosphorylated for some patients belonging to Group A showed values closer to non-AD subjects (Group B), even if the clinical parameters and conditions were reflective of AD. This evidence concerns the gene MAPT and Alzheimer disease.